106531-50-4

Usage

Uses

Used in Pharmaceutical Industry:
ETHYL 3-HYDROXYFURO[2,3-C]PYRIDINE-2-CARBOXYLATE is used as an active pharmaceutical ingredient for the development of new drugs and therapeutic agents. Its unique molecular structure allows it to interact with biological targets, making it a promising candidate for various medical applications.
Used in Agrochemical Industry:
In the agrochemical industry, ETHYL 3-HYDROXYFURO[2,3-C]PYRIDINE-2-CARBOXYLATE is used as a key component in the synthesis of pesticides, herbicides, and other crop protection agents. Its chemical properties enable it to effectively target and control pests and weeds, contributing to increased crop yields and agricultural productivity.
Used in Dye Industry:
ETHYL 3-HYDROXYFURO[2,3-C]PYRIDINE-2-CARBOXYLATE is utilized in the dye industry as a building block for the synthesis of various dyes and pigments. Its heterocyclic structure imparts unique color properties, making it suitable for use in textiles, plastics, and other applications requiring vibrant and stable colorants.
While the specific applications of ETHYL 3-HYDROXYFURO[2,3-C]PYRIDINE-2-CARBOXYLATE may vary across different industries, its presence in these sectors highlights its potential for diverse uses. Its unique molecular structure and chemical properties make it a valuable compound for research, development, and innovation in various fields.

InChI:InChI=1/C10H9NO4/c1-2-14-10(13)9-8(12)6-3-4-11-5-7(6)15-9/h3-5,12H,2H2,1H3

Upstream product

• 18343-02-7 Ethyl 2-(4-Ethoxycarbonyl-3-pyridyloxy) acetate 
• 10128-71-9 3-hydroxyisonicotinic acid 
• 18342-97-7 ethyl 3-hydroxyisonicotinate 

Downstream Products

• 106531-51-5 Furo<2,3-c>pyridin-3(2H)-one hydrochloride 
• 927804-63-5 ethyl 3-(((trifluoromethyl) sulfonyl)oxy)furo[2,3-c]pyridine-2-carboxylate 
• 106531-52-6 furo[2,3-c]pyridin-3(2H)-one 
• 1454284-75-3 N-(4-(6-methylpyridin-3-ylsulfonyl)benzyl)furo[2.3-c]pyridine-2-carboxamide 
• 1454284-57-1 furo[2,3-c]pyridine-2-carboxylic acid 4-(tetrahydropyran-4-ylsulfamoyl)benzylamide 
• 1454250-96-4 (R)-N-([5-[(3,5-difluorobenzene)sulfinyl]pyridin-2-yl]methyl)furo[2,3-c]pyridin-2-carboxamide 
• 1454250-97-5 (S)-N-([5-[(3,5-difluorobenzene)sulfinyl]pyridin-2-yl]methyl)furo[2,3-c]pyridin-2-carboxamide 
• 1454250-93-1 N-([5-[(3,5-difluorobenzene)sulfinyl]pyridin-2-yl]methyl)furo[2,3-c]pyridin-2-carboxamide 
• 1454250-90-8 furo[2,3-c]pyridin-2-carboxylic acid [5-(3-trifluoromethylbenzenesulfonyl)pyridin-2-ylmethyl]amide 
• 1448536-37-5 N-{[4-(piperidine-1-sulfonyl)phenyl]methyl}furo[2,3-c]pyridine-2-carboxamide 
• 1453175-46-6 C₂₄H₂₉N₃O₃S 
• 1453175-45-5 C₂₄H₂₉N₃O₃S 
• 1453176-79-8 4-{[(furo[2,3-c]pyridine-2-carbonyl)-amino]-methyl}-benzenesulfonyl chloride 
• 1453176-78-7 furo[2,3-c]pyridine-2-carboxylic acid benzylamide 

Relevant academic research and scientific papers

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

The invention relates to heterocyclic amide derivatives of formula (I), wherein R1, R2, R3, R4, R5, X, Y and n are as defined in the description, their preparation and their use as pharmaceutically active compounds.

AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES

The present invention relates to certain amido-benzyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.

PYRIDINYL AND PYRIMIDINYL SULFOXIDE AND SULFONE DERIVATIVES

Disclosed are certain pyridinyl and pyrimidinyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds and methods of treatment using such compounds.

AMIDO-BENZYL SULFONE AND SULFONAMIDE DERIVATIVES

Disclosed are certain amido-benzyl sulfone and sulfonamide compounds, pharmaceutical compositions comprising such compounds, land methods of treatment using such compounds.

ALKYL-AND DI-SUBSTITUTED AMIDO-BENZYL SULFONAMIDE DERIVATIVES

The present invention relates to certain alkyl- and di-substituted amido-benzyl sulfonamide compounds, pharmaceutical compositions comprising such compounds, and to methods of treatment of NAMPT-mediated disorders, such as diabetes, rheumatoid arthritis,

AMIDO SPIROCYCLIC AMIDE AND SULFONAMIDE DERIVATIVES

Provided are amido spirocyclic amide and sulfonamide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.

AMIDO-BENZYL SULFOXIDE DERIVATIVES

The present invention relates to certain amido-benzyl sulfoxide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment of an NAMPT-mediated disease or condition in a subject, selected from solid or liquid tumor, rheumat

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

The invention relates to heterocyclic amide derivatives of formula (I), wherein R1, R2, R3, R4, R5, X, Y and n are as defined in the description, their preparation and their use as pharmaceutically active compounds.

The discovery of furo[2,3-c]pyridine-based indanone oximes as potent and selective B-Raf inhibitors

Virtual and high-throughput screening identified imidazo[1,2-a]pyrazines as inhibitors of B-Raf. We describe the rationale, SAR, and evolution of the initial hits to a series of furo[2,3-c]pyridine indanone oximes as highly potent and selective inhibitors

RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF

Compounds of Formulas (I), (IIA) and (IIIA) are useful for inhibiting Raf kinase and for treating disorders mediated thereby. Methods of using compounds of Formulas (I), (IIA) and (IIIA) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.